Merrimack Pharmaceuticals, Inc. (MACK)

Oncology Corporate Profile

Stock Performance

7.2100
-0.1300

HQ Location

One Kendall Square, Suite B7201
Cambridge, MA 2139

Company Description

Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies its systems biology-based approach to biomedical research throughout the research and development process. Merrimack currently has six targeted therapeutic oncology therapeutics in clinical development.

Website: http://www.merrimackpharma.com

Brand Generic Indication
Onivyde®irinotecan liposome injectionOnivyde® is a topoisomerase inhibitor indicated, in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
MM-398nanotherapeutic2nd line metastatic Pancreatic cancerIII
MM-398nanotherapeuticColorectal cancerIII
MM-111 (+ aclitaxel and trastuzumab)bi-specific antibody (anti-ErbB3 & anti-ErbB2)2nd line metastatic Gastric cancerII
MM-121 (+ paclitaxel)anti-erbb3 monoclonal antibodyBreast cancerII
MM-121 (+ exemestane)anti-erbb3 monoclonal antibodyBreast cancerII
MM-302nanotherapeuticBreast cancer (HER2+)II
MM-121 (+ erlotinib)anti-erbb3 monoclonal antibodyNon Small Cell Lung Cancer (NSCLC)II
MM-121anti-erbb3 monoclonal antibodyNon Small Cell Lung Cancer (NSCLC)II
MM-121 (+ paclitaxel)anti-erbb3 monoclonal antibodyOvarian cancerII
MM-398nanotherapeuticGliomaI
MM-398nanotherapeuticPediatric cancerI
MM-141bi-specific tetravalent antibody (ErbB3 & IGF-1R)Various cancer typesI
MM-310antibody-directed nanotherapeutic (ADN)Various cancer typesI
MM-151anti-egfr oligoclonal antibodyVarious cancer typesI
MM-141 (+ everolimus and docetaxel)bi-specific tetravalent antibody (ErbB3 & IGF-1R)Various cancer typesI
MM-131multispecific antibodyVarious cancer typesPreclinical

View additional information on product candidates here »

Source: http://www.merrimackpharma.com

Recent News Headlines

5/27/2017 06:18 am

5/27/2017 06:18 am

5/27/2017 06:18 am

5/27/2017 06:18 am

5/27/2017 06:18 am

5/25/2017 12:18 pm

5/25/2017 12:18 pm

5/25/2017 12:18 pm

5/25/2017 12:18 pm

5/25/2017 12:18 pm

5/11/2017 06:18 am

5/11/2017 06:18 am

5/11/2017 06:18 am

5/11/2017 06:18 am

5/10/2017 06:18 pm

5/10/2017 06:18 am

5/10/2017 12:18 am

5/2/2017 12:18 pm

4/27/2017 06:18 am

4/27/2017 06:18 am

4/19/2017 12:18 pm

4/19/2017 12:18 pm

4/19/2017 12:18 pm

4/19/2017 12:18 pm

4/19/2017 12:18 pm